Abstract
Background/aims
Although many proton magnetic resonance spectroscopy studies have assessed the relative ratios of brain metabolites from patients with dementia, absolute quantification is rare. The aim of this study is to compare the diagnostic accuracy of these 2 methods in proton magnetic resonance spectroscopy in discriminating Alzheimer's disease (AD) and Binswanger's disease (BD) from healthy controls (HC).Methods
The subjects were 30 AD patients, 13 BD patients and 26 HC subjects. Single-voxel proton MR spectra at short echo times were acquired from 8 volumes of interest.Results
At 80% specificity, the absolute N-acetylaspartate concentration in the hippocampus was the most sensitive measure to discriminate AD from HC, and the absolute N-acetylaspartate concentration in the anterior periventricular and deep white matter to differentiate BD from HC and AD. No relative ratio using creatine as a reference had a sensitivity over 80% at 80% specificity. The cause of disparities between the 2 methods was attributed to fluctuations in the creatine concentration.Conclusion
Our study revealed that absolute quantification is superior to relative ratio to differentiate AD and BD from HC.Citations & impact
Impact metrics
Citations of article over time
Article citations
Reduced GABA concentration in patients with white matter hyperintensities.
Front Neurosci, 17:1320247, 14 Dec 2023
Cited by: 0 articles | PMID: 38156270 | PMCID: PMC10752961
Spatio-temporal metabolic rewiring in the brain of TgF344-AD rat model of Alzheimer's disease.
Sci Rep, 12(1):16958, 10 Oct 2022
Cited by: 1 article | PMID: 36216838 | PMCID: PMC9550832
Effect of high-intensity interval training on hippocampal metabolism in older adolescents.
Psychophysiology, 59(11):e14090, 22 May 2022
Cited by: 11 articles | PMID: 35599295 | PMCID: PMC9787522
Chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in Alzheimer's disease.
Alzheimers Res Ther, 14(1):53, 13 Apr 2022
Cited by: 13 articles | PMID: 35418161 | PMCID: PMC9006585
Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies.
Ageing Res Rev, 72:101503, 29 Oct 2021
Cited by: 78 articles | PMID: 34751136 | PMCID: PMC8662951
Review Free full text in Europe PMC
Go to all (25) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Prog Neuropsychopharmacol Biol Psychiatry, 28(8):1313-1322, 01 Dec 2004
Cited by: 29 articles | PMID: 15588758
Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
Ann Neurol, 36(1):40-47, 01 Jul 1994
Cited by: 95 articles | PMID: 8024260
Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
Dement Geriatr Cogn Disord, 26(1):15-25, 20 Jun 2008
Cited by: 18 articles | PMID: 18566544
1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
Neurol Res, 26(5):488-495, 01 Jul 2004
Cited by: 55 articles | PMID: 15265265
Review